DANIEL MUSHER to Polysaccharides, Bacterial
This is a "connection" page, showing publications DANIEL MUSHER has written about Polysaccharides, Bacterial.
Connection Strength
2.519
-
Specific Polysaccharide Antibody Deficiency. Clin Infect Dis. 2023 09 18; 77(6):932-933.
Score: 0.873
-
Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia. Clin Infect Dis. 2006 Oct 15; 43(8):1004-8.
Score: 0.268
-
Genetic control of the immunologic response to pneumococcal capsular polysaccharides. Vaccine. 2000 Nov 08; 19(6):623-7.
Score: 0.179
-
Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia. J Infect Dis. 2000 Jul; 182(1):158-67.
Score: 0.175
-
IgG responses to protein-conjugated pneumococcal capsular polysaccharides in persons who are genetically incapable of responding to unconjugated polysaccharides. Clin Infect Dis. 1998 Dec; 27(6):1487-90.
Score: 0.157
-
Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia. Ann Am Thorac Soc. 2015 Oct; 12(10):1482-9.
Score: 0.126
-
Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clin Infect Dis. 1993 Jul; 17(1):66-73.
Score: 0.108
-
Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4. Infect Immun. 1990 Dec; 58(12):3871-6.
Score: 0.090
-
Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916. Infect Immun. 1990 Sep; 58(9):3135-8.
Score: 0.088
-
Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis. 1990 Apr; 161(4):728-35.
Score: 0.086
-
Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection? J Infect Dis. 1990 Apr; 161(4):736-40.
Score: 0.086
-
Vaccination of 18-month-old children with conjugated polyribosyl ribitol phosphate stimulates production of functional antibody to Haemophilus influenzae type b. Pediatr Infect Dis J. 1988 Mar; 7(3):156-9.
Score: 0.074
-
Immunity to Haemophilus influenzae type b in young adults: correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination. J Infect Dis. 1986 Dec; 154(6):935-43.
Score: 0.068
-
Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users. Vaccine. 2002 Nov 01; 20(31-32):3720-4.
Score: 0.051
-
Protection against bacteremic pneumococcal infection by antibody to pneumolysin. J Infect Dis. 2001 Mar 01; 183(5):827-30.
Score: 0.045
-
Mitogenic activity of bacterial lipopolysaccharides in vivo: morphological and functinal characterization of responding cells. Infect Immun. 1978 Jan; 19(1):71-8.
Score: 0.037
-
Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis. 1996 Jan; 173(1):83-90.
Score: 0.008